GLAXOSMITHKLINE Awarded $279.86 Million Army Contract
Copyright © Targeted News Service 2021
2021-10-04
WASHINGTON, Oct. 4 -- The U.S. Army Contracting Command issued the following high-value contract information through the Pentagon on Sept. 30, 2021:
GLAXOSMITHKLINE, Durham, North Carolina, was awarded a $279,862,800 firm-fixed-price contract (W58P05-21-C-0008) for procurement, storage, and distribution of GlaxoSmithKline's monoclonal antibody therapeutic treatment Sotrovimab.
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting act . . .
GLAXOSMITHKLINE, Durham, North Carolina, was awarded a $279,862,800 firm-fixed-price contract (W58P05-21-C-0008) for procurement, storage, and distribution of GlaxoSmithKline's monoclonal antibody therapeutic treatment Sotrovimab.
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting act . . .
